Boston Scientific
BSX · NYSE · USD · Healthcare
Price
+2.9% since 20/07/20263 months · High $52.99 (-15.0%) · Low $41.39
What is happening
Boston Scientific has fallen 5% since its 6-week high on 08/09/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayHow deep is the dip?
- from the 6-week high-5.1%
Highest daily price: $47.45 on 08/09/2026 · reference of the assessment
- from the 3-month high-15.0%
Highest daily price in 3 months: $52.99 on 14/08/2026
- from the 52-week high-57.4%
Highest price in 52 weeks: $105.65 (Yahoo)
Marking places no order – it only helps you keep track.
Catalysts
3 h ago- News, last 10 days
- no recent news
- Next earnings
- 28/10/2026 · in 8 days
- Last report
- 29/07/2026 +3.9% vs estimate
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
About Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
- Headquarters:
- Marlborough, United States
- 52-week range:
- $41.39 – $105.65
- Website:
- bostonscientific.com
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
